Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic hemopoietic stem cell transplantation in solid tumors.

F Carnevale-Schianca1, A Ricchiardi, A Capaldi

  • 1Medical Oncology, Department of Oncological Sciences, University of Turin Medical School, Institute for Cancer Research and Treatment (I.R.C.C.), Candiolo, Turin, Italy.

Transplantation Proceedings
|September 27, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network.

ESMO open·2026
Same author

Energy Spectrum of Ultrahigh-Energy Cosmic Rays across Declinations -90° to +44.8° as Measured at the Pierre Auger Observatory.

Physical review letters·2026
Same author

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025

The graft versus tumor (GVT) effect, crucial in blood cancer treatment, is now being explored for solid tumors. Novel, less toxic transplant methods enable this investigation, showing early promise for a new immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • The graft versus tumor (GVT) effect, mediated by donor T cells, is vital for allogeneic hematopoietic stem cell transplantation success in hematologic malignancies.
  • Investigating GVT in solid tumors has been limited by the high morbidity associated with conventional transplantation regimens.
  • Recent advancements in allogeneic nonmyeloablative transplantation have significantly reduced transplant-related morbidity and mortality, preserving GVT efficacy.

Purpose of the Study:

  • To review early clinical results of allogeneic nonmyeloablative transplantation as a novel immunotherapy for solid tumors.
  • To explore the potential of alloreactivity toward solid tumors in the context of reduced-toxicity transplantation.

Main Methods:

  • Review of early clinical data from patients with solid tumors undergoing allogeneic nonmyeloablative transplantation.

Related Experiment Videos

  • Focus on the GVT effect and its implications for solid tumor treatment.

    • Main Results:

    • Early clinical results indicate the feasibility of exploring GVT in solid tumors using less toxic transplant regimens.
    • The reduced morbidity of nonmyeloablative allogeneic transplantation allows for the investigation of GVT's potential in refractory solid tumors.

    Conclusions:

    • Allogeneic nonmyeloablative transplantation offers a promising avenue for investigating the GVT effect in solid tumors.
    • This approach represents a novel immunotherapeutic strategy with the potential to improve outcomes for patients with refractory solid tumors.